English   español  
Por favor, use este identificador para citar o enlazar a este item: http://hdl.handle.net/10261/21236
Compartir / Impacto:
Estadísticas
Add this article to your Mendeley library MendeleyBASE
Citado 79 veces en Web of Knowledge®  |  Pub MebCentral Ver citas en PubMed Central  |  Ver citas en Google académico
Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL
Título

Matrix Metalloproteinase-9 Promotes Chronic Lymphocytic Leukemia B Cell Survival through Its Hemopexin Domain

AutorRedondo-Muñoz, Javier; Ugarte-Berzal, Estefanía ; Terol, María José; Steen, Philippe E. Van den; Hernández del Cerro, Mercedes ; Roderfeld, Martin; Roeb, Elke; Opdenakker, Ghislain; García-Marco, José A.; García-Pardo, Angeles
Palabras claveB-CLL cells
MMP-9
Fecha de publicación17-feb-2010
EditorElsevier
CitaciónCancer Cell 17(2): 160-172 (2010)
ResumenMatrix metalloproteinase-9 (MMP-9) is the major MMP produced by B-CLL cells and contributes to their tissue infiltration by degrading extracellular and membrane-anchored substrates. Here we describe a different function for MMP-9 in B-CLL, which involves the hemopexin domain rather than its catalytic function. Binding of soluble or immobilized (pro)MMP-9, a catalytically inactive proMMP-9 mutant, or the MMP-9 hemopexin domain to its docking receptors α4β1 integrin and CD44v, induces an intracellular signaling pathway that prevents B-CLL apoptosis. This pathway is induced in all B-CLL cases, is active in B-CLL lymphoid tissues, and consists of Lyn activation, STAT3 phosphorylation, and Mcl-1 upregulation. Our results establish that MMP/receptor binding induces intracellular survival signals and highlight the role of (pro)MMP-9 in B-CLL pathogenesis
Versión del editor10.1182/blood-2007-08-107300
URIhttp://hdl.handle.net/10261/21236
DOI10.1016/j.ccr.2009.12.044
ISSN1535-6108
Aparece en las colecciones: (CIB) Artículos
Ficheros en este ítem:
No hay ficheros asociados a este ítem.
Mostrar el registro completo
 



NOTA: Los ítems de Digital.CSIC están protegidos por copyright, con todos los derechos reservados, a menos que se indique lo contrario.